Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria
Abstract Background As part of implementation quality standards, community distributors are expected to ensure that only age-eligible children (aged 3–59 months) receive seasonal malaria chemoprevention (SMC) medicines during monthly campaigns. There is uncertainty about the extent to which SMC medi...
Main Authors: | Taiwo Ibinaiye, Kunle Rotimi, Ayodeji Balogun, Adaeze Aidenagbon, Chibuzo Oguoma, Christian Rassi, Kevin Baker, Olusola Oresanya, Chuks Nnaji |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12936-024-04916-z |
Similar Items
-
Urban–rural differences in seasonal malaria chemoprevention coverage and characteristics of target populations in nine states of Nigeria: a comparative cross-sectional study
by: Taiwo Ibinaiye, et al.
Published: (2024-01-01) -
Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad, and Togo
by: Taiwo Ibinaiye, et al.
Published: (2023-05-01) -
Spontaneous adverse drug reaction reporting during the seasonal malaria chemoprevention campaign in 2022
by: Kunle Rotimi, et al.
Published: (2023-05-01) -
Pharmacovigilance reporting during seasonal malaria chemoprevention campaign: Findings from northern Nigeria
by: Kunle Rotimi, et al.
Published: (2022-09-01) -
Making the most of malaria chemoprevention
by: Jasper Littmann, et al.
Published: (2024-02-01)